France· FR:66829076
EBVALLO 2,8 x 10 000 000 - 7,3 x 10 000 000 cellules/mL, dispersion injectable
A tabelecleucel product containing tabélecleucel, registered in France by PIERRE FABRE MEDICAMENT. The same ATC class is registered in 11 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Tabelecleucel is registered in 11 of 19 countries.
Countries holding a registration under ATC L01XL09 (tabelecleucel), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Tabelecleucel · ATC L01XL09
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TABÉLECLEUCEL
- Manufacturer
- PIERRE FABRE MEDICAMENT
- Country
- France (FR)
- ATC code
- L01XL09
- ATC class
- Tabelecleucel
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550946541 à 6 flacons copolymère de cyclooléfines (COC) de 1 mL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tabelecleucel in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEbvallo 2.8 10*7 cells/ml - 7.3 10*7 cells/mlPierre Fabre Médicament
- SwitzerlandEbvallo, InjektionsdispersionPierre Fabre Pharma SA
- CzechiaEBVALLOPIERRE FABRE MEDICAMENT, Lavaur
- SpainEBVALLO 2,8 × 10E7 - 7,3 × 10E7 CÉLULAS /ML DISPERSION INYECTABLEPierre Fabre Medicament
- FinlandEbvalloPierre Fabre Medicament
- IrelandEbvallo 2.8 × 10^7 – 7.3 × 10^7 cells/mL dispersion for injectionPierre Fabre Medicament
- IcelandEbvalloPierre Fabre Medicament
- NetherlandsEbvallo 5×10E7 cellen/ml, dispersie voor injectiePierre Fabre Medicament
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ebvallo
- Liechtenstein · Ebvallo
- Norway · Ebvallo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9a29f54a-4a24-471a-9eb9-12e9b7a119b0 GET /v1/drugs/9a29f54a-4a24-471a-9eb9-12e9b7a119b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66829076",
"date_amm": "2022-12-16",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/22/1700",
"substance": "TABÉLECLEUCEL",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "dispersion injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about tabelecleucel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.